Home Markets Up more than 15% in January alone, these stocks are poised to keep outperforming

Up more than 15% in January alone, these stocks are poised to keep outperforming

Andrew M Jan 25, 2025 comments off

US FDA approves expanded use of Moderna’s RSV vaccine for at-risk adults